Saturday, Sep 21 2019 | Time 03:52 Hrs(IST)
image
  • Honey trap: 3 in judicial custody
  • Some 91 Heads of State to Attend UNGA in New York Next Week - Spokesman
  • Nation in financial doldrums due to Modi team’s actions: MP CM
  • 12 killed in bomb explosion in Iraq's Karbala
  • MP floods: Team briefs CM
  • Nine People Killed, 4 Injured in Explosion in Minibus in Central Iraq - Reports
  • Russia Suspected of Manipulating Doping Data From Moscow Lab - Reports
  • Trump, Zelenskyy to Discuss Russia, China Activities at UNGA Wednesday - US Official
  • ATS files charge sheet against two members of extremist organisations
  • Moderate tremor hits Palghar
  • Pawar attacks BJP, Modi
  • People from 20 countries speaking 30 languages to grace 'Howdy Modi' mega show
  • FCI regional office to be opened at Imphal: Paswan
  • Investigating officers in Bihar don't know how to behave with women: NCW
Business Economy


Dr Reddy's Laboratories launches Versavo in India

Hyderabad, Aug 19 (UNI) Dr Reddy’s Laboratories Limited on Monday said that it has launched Versavo (bevacizumab), a biosimilar of Roche’s Avastin in India.

It would be used for treatment of several types of cancers (metastatic colorectal cancer, non-squamous non-small cell lung cancer, recurrent glioblastoma, metastatic renal cell carcinoma, cervical cancer, metastatic breast cancer and epithelial ovarian, fallopian tube and primary peritoneal cancer).

Dr Reddy’s Versavo is available in strengths of 100 mg and 400 mg single use vials, a company statement here said.

Commenting on the launch, MV Ramana, CEO - India and Emerging Markets, Dr Reddy’s Laboratories, said, “We regard the good health of our patients as our responsibility and are committed to ensure that they always have access to the medicines they need. The launch of Versavo® is another step in that journey and helps strengthen our Oncology portfolio.”

Dr Raymond De Vré, Global Head, Biologics, Dr Reddy’s Laboratories added “Versavo will help improve access to high quality therapy at an affordable cost, addressing the needs of patients with different cancers in India.”

Avastin and its biosimilars had India sales of approximately Rs 223 crore MAT for the most recent twelve months ending in December 2018, according to Ipsos.

Dr Reddy’s now has six biosimilar products commercialized in India and various emerging markets and an active development pipeline of several biosimilar products in the oncology and immunology space, the statement added.
UNI VV CS 1407
More News
GST announces tax relief for FIFA under-17 Women's WC 2020

GST announces tax relief for FIFA under-17 Women's WC 2020

20 Sep 2019 | 10:52 PM

Panaji, Sep 20 (UNI) Union Finance Minister Nirmala Sitharaman on Friday announced that the 37th Goods and Services Council had decided to exempt services related to the upcoming FIFA under-17 Women's World Cup from tax bracket.

see more..

GST rates on hotel room tariff slashed

20 Sep 2019 | 10:23 PM

Panaji, Sep 20 (UNI) Goods and Services Tax Council (GST) Council on Friday announced cut in GST rates on hotel room tariff.

see more..

Wipro Consumer Care & Lighting sets up a venture fund to invest in start-ups

20 Sep 2019 | 7:30 PM

Kolkata, Sep 20 (UNI) Wipro Consumer Care and Lighting has launched Wipro Consumer Care - Ventures.

see more..

Leaders across industries welcome FM's corporate tax cuts

20 Sep 2019 | 7:27 PM

Kolkata, Sep 20 (UNI) The industry leaders and market experts welcomed Finance Minister Nirmala Sitharaman's decision to slash corporate tax for domestic companies and newly formed manufacturing domestic companies to 22 per cent and 15 per cent respectively, aimed to put the growth engine back on track.

see more..

EAC-PM welcomes Govt measures to revive economic sentiment

20 Sep 2019 | 7:22 PM

New Delhi, Sep 20 (UNI) Union Finance Minister Nirmala Sitharaman made path-breaking announcements on Friday by revising the corporate tax rate downward and altering the percentage and application of Minimum Alternate Tax in certain cases.

see more..
image